Faculty

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Human Resources for Health in Rwanda

Shubhada Hooli, MD, MPH
Samantha Rosman, MD
Daphne Remy, MD

Affiliated Faculty

Lara Antkowiak, MD
MaryCatherine Arbour, MD, MPH
Natasha Archer, MD
Lisa Butler, PhD, MPH
Grace Chan, MD, PhD, MPH
Christopher Duggan, MD, MPH
Sara Gonzalez, DO
Anne Hansen, MD, MPH
Vibha Krishnamurthy, MD
Anne CC Lee, MD, MPH
Leslie Lehmann, MD
Duncan Maru, MD, PhD
Kenneth McIntosh, MD
Carlos Rodriguez-Galindo, MD
Peter Rohloff, MD, PhD
Dennis Rosen, MD
Sadath Sayeed, MD, JD
Janet Scott Lloyd, MD
Diane Stafford, MD
Venee Tubman, MD
Jill Veselik, MD
Julia von Oettingen, MD


Lara Antkowiak, MD

Associate Professor of Pediatrics, Harvard Medical School; Associate Professor in the Department of Nutrition, Harvard School of Public Health; Director, Center for Nutrition, Boston Children’s Hospital; Medical Director, Center for Advanced Intestinal Rehabilitation (CHAIR), Boston Children’s Hospital




MaryCatherine Arbour, MD, MPH

Associate Physician, Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital; Senior Research Associate, Center on the Developing Child, Harvard Medical School; Instructor in Medicine, Harvard Medical School;

Dr. Arbour performs global health research aimed at designing and evaluating interdisciplinary, community-based interventions with the goal of reducing inequities and a special interest in child development. She directed the health component of Un Buen Comienzo, a cluster-randomized controlled trial of a preschool health and education intervention in Santiago, Chile. She leads the integration of continuous quality improvement methods in the expansion of UBC to a rural Region. In the United States, she leads quality improvement methods as Improvement Advisor for the Health Services Research Administration’s national Home Visiting Collaborative for Improvement and Innovation (HV CoIIN). Through HV CoIIN, sixteen states and two tribal grantees aim to improve the home visiting services they provide to at-risk families with young children, specifically in the areas of developmental surveillance and screening, breastfeeding extension, maternal depression and family engagement. Dr. Arbour has also performed early childhood interventions and research in post-disaster settings, including post-tsunami Indonesia (2005), post-earthquake Haiti (2010), and post-earthquake Chile (2010). Dr. Arbour holds a BA in Biological Anthropology from Swarthmore College, an MD from Harvard Medical School and an MPH from the Harvard School of Public Health.


Natasha Archer, MD

Associate Physician, Internal Medicine, Division of Global Health Equity, Brigham and Women’s Hospital; Assistant, Medicine, Boston Children’s Hospital; Instructor, Pediatrics, Dana-Farber Cancer Institute; Instructor, Pediatrics, Harvard Medical School; Senior Health and Policy Advisor in Hematology, Partners In Health;

Early in my medical career, I decided to focus on global health. As a Doris and Howard Hiatt Global Health Equity Resident at Brigham and Women’s Hospital and Boston Children’s Hospital, I was able to spend 25-50% of my time during residency working in resource limited settings like Haiti, Rwanda, and Lesotho. While working in those countries, I realized the extreme disparities in health outcomes for pediatric patients with cancer and blood disorders. In speaking with my Haitian colleagues, the need for a sickle cell disease program became apparent. I entered a pediatric hematology and oncology fellowship at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center with the goal to develop a sickle cell disease newborn screening and management program and to study the most effective ways to provide care for children with the disease. During the last two years, I have led the development a sickle cell disease newborn screening and management program in Mirebalais, Haiti. My work establishing a sickle cell disease newborn screening and management program has developed a clinical research platform that I can continue to build upon. As an early career physician-scientist in pediatric hematology and oncology, my clinical and research activities will focus on improving the clinical outcomes of children with sickle cell disease and other cancer and blood disorders both domestically and globally.


Lisa Butler, PhD, MPH, PhD

Associate Scientific Researcher, Division of General Pediatrics, Boston Children's Hospital; Lecturer on Pediatrics, Harvard Medical School;

Dr. Lisa Butler is an epidemiologist and behavioral scientist with research interests in child and adolescent HIV prevention, care and treatment. She has education and training in educational psychology (PhD, University of California Los Angeles, 2000) and epidemiology (MPH, University of California Berkeley, 2002; PhD, University of California Berkeley, 2009). Between 2002-2005, she was a post-doctoral fellow at The University of California San Francisco’s (UCSF) Center for AIDS Prevention Studies (CAPS). From 2005-2010, she was supported by a five-year NIH K01 award, which supported her research on Kaposi’s sarcoma-associated herpesvirus transmission in South Africa and Uganda as well as further training and research focused more broadly on pediatric HIV and child health. Prior to joining the faculty at Boston Children’s Hospital and Harvard Medical School in 2013, she was Assistant Professor at UCSF in the Department of Epidemiology and Biostatistics.
Dr. Butler has over 16 years’ research experience in community- and clinic- settings in sub-Saharan Africa, including South Africa, Uganda, Kenya, Ghana, and more recently, Tanzania and Zanzibar. Dr. Butler’s primary research interests are in the design and implementation of randomized controlled trials and observational studies of maternal, neonatal and child health, and infectious diseases, with emphasis on HIV. She has particular strength in designing and testing multi-faceted, complex interventions that integrate with existing community- or clinic- programs in low-resource settings. Her work is multi-disciplinary, including collaborations with clinical researchers, psychologists, learning scientists, epidemiologists, agricultural scientists, and computer scientists as well as experts in communications and media design. She places a high value on the translation of her work from research to program and policy, maintaining close affiliations with non-governmental and governmental organizations.


Grace Chan, MD, MPH, PhD

Attending Physician, Intermediate Care Program, Division of Medical Critical Care, Boston Children’s Hospital; Instructor in Pediatrics, Harvard Medical School; Instructor, Department of Global Health and Population, Harvard School of Public Health

Dr. Chan is a graduate of Harvard College, Harvard Medical School, and Johns Hopkins School of Public Health. She trained in pediatrics at Boston Children’s Hospital and conducted research as a fellow at the International Center for Diarrheal Disease Research, Bangladesh. As an NIH Clinical Research Scholar, she completed a dissertation on the maternal origins of neonatal infection in Bangladesh. Her research activities focus on using epidemiologic methods to advance child health. With collaborators in India, Indonesia, and Tanzania, she has led studies to understand the causes of neonatal mortality and implemented programs and to improve the quality and delivery of cost-effective interventions on essential newborn care.


Christopher Duggan, MD, MPH

Associate Professor of Pediatrics, Harvard Medical School; Associate Professor in the Department of Nutrition, Harvard School of Public Health; Director, Center for Nutrition, Boston Children’s Hospital; Medical Director, Center for Advanced Intestinal Rehabilitation (CHAIR), Boston Children’s Hospital

For the past 20 years, Christopher Duggan, M.D., M.P.H. has been performing clinical trials in the fields of pediatric nutrition, gastroenterology and global health. His early work centered on the management of diarrheal diseases in children, including trials that demonstrated the feasibility and efficacy of oral rehydration solutions (ORS) for diarrhea management in the US and globally. In collaboration with colleagues at Harvard and Muhimbili University of Health and Allied Sciences in Dar es Salaam, Tanzania, Dr. Duggan is evaluating the efficacy of micronutrient supplementation in infants and young children born to women with or at risk of HIV infection, as well as investigating the role of biomarkers to detect environmental enteropathy. With colleagues at St John's Research Institute in Bangalore, India, he is evaluating the efficacy of maternal vitamin B12 supplementation on biochemical and clinical parameters during pregnancy and infancy. Past and present research support has come from the National Institutes of Health, the Bill and Melinda Gates Foundation, and numerous foundations.


Sara Gonzalez, DO

Attending Physician, St. Luke's Hospital (New Bedford, MA)

Dr. Gonzalez is a board-certified osteopathic pediatrician. Sara Gonzalez is a global pediatrics fellow at Children's Hospital Boston with an interest in applying QI methodology to improve delivery of healthcare in resource-limited settings. She graduated in 2004 from University of Scranton with a BS in Neuroscience and Philosophy. She then attended Touro University College of Osteopathic Medicine - California. She went on to complete her pediatrics residency at Geisinger Medical Center, Danville PA, where she began learning and applying QI methodology to improve delivery of pediatric care within the hospital system. During that time she worked in Honduras and Namibia with Geisinger's support. She completed her Global Pediatrics Fellowship at Boston Children’s Hospital/Partners in Health in 2013.


Anne Hansen, MD, MPH

Associate in Medicine, Medical Director, Neonatal Intensive Care Unit, Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School

Dr. Hansen’s global health work is focused on improving newborn medicine in Rwanda, in collaboration with Rwandan health care providers, professional societies, the ministry of health and Partners In Health (PIH). Starting in 2010, Dr Hansen began to help develop and implement a newborn medicine protocol that has been accepted as the Rwandan national standard for newborn care. Since then she has worked to increase capacity, including the use of bubble CPAP. Most recently she has helped write the 2nd edition of the National Protocol to reflect this increased capacity, with planned national training in 2015. She has also working with Lawrence Berkeley Laboratory’s Institute for Globally Transformative Technologies (LIGGT) and PIH since 2012 to develop and test a non-electric infant warmer. This project is currently approaching completion of prototype development and safety testing, and is expected to move to clinical trials in Rwanda in 2105. Finally, she is working with the Wyss Institute to develop a bedside test as an alternative to the blood culture in the resource limited setting, based on a modified version of Mannose Binding Lectin, engineered to capture small quantities of bacteria in a blood sample. This project is still in the development phase. In addition to her efforts in global health, she works to improve the care of newborns seriously ill with medical and surgical conditions. She has authored both original research papers and manuals for neonatologists, surgeons and pediatricians, developed multiple guidelines for the CHB NICU, and collaborated with numerous investigators on medical and technical improvements to care. For surgical patients, she co-edited The Manual of Neonatal Surgical Intensive Care, editions 1 to 3. She has written multiple guidelines for pre and post operative management. She was a lead investigator in a study of Donation after Cardiac Death (DCD) in the NICU that resulted in offering this option in the CHB NICU. She is currently working with a team that includes BCH surgery and the Wyss Institute to develop a novel, minimally invasive approach to growth induction via stretch, applicable to patients with long gap esophageal atresia. For medical patients, she has co-edited the Manual of Neonatal Care, and studied innovative approaches to the treatment of neonatal conditions including intraventricular urokinase for the prevention of posthemorrhagic hydrocephalus, once daily gentamicin dosing in infants, substitution of cord for infant blood in peri-natal sepsis evaluations, and inhaled racemic epinephrine for the treatment of TTN. In collaboration with her neurology colleagues, she helped develop and implement the first therapeutic hypothermia program in New England and is collaborating on studies of sophisticated MRI and NIRS technology to better assess neurologic function and outcome.


Vibha Krishnamurthy, MBBS, MD

Founder and Medical Director, Ummeed Child Development Center; Consultant Developmental Pediatrician, Jaslok Hospital and Research Centre, Mumbai; Consultant, WHO (WHO guideline development group for disability, expert committee on ECD, and Autism)

Vibha Krishnamurthy is a developmental pediatrician who trained at Children’s Hospital Boston. She is currently Founder and Medical Director of Ummeed Child Development Center in Mumbai, India. Ummeed is a not for profit that focuses on children with disabilities and their families, through direct services, training, advocacy and research. Her research focus currently is a 5 year NIH funded project with 3 other low and middle income countries, for the standardization and validation of a tool to monitor child development, the IGMCD ( International Guide for Monitoring Child Development).


Anne CC Lee, MD, MPH

Pediatrician, Department of Newborn Medicine, Brigham and Women’s Hospital; Instructor in Pediatrics, Harvard Medical School; Associate, Department of International Health, Johns Hopkins Bloomberg School of Public Health

Anne CC Lee, MD, MPH, FAAP, is a pediatrician in the Department of Newborn Medicine at Brigham and Women’s Hospital and Harvard Medical School and an Associate in the Department of International Health, Johns Hopkins Bloomberg School of Public Health. She is a member of the Child Epidemiology Reference Group Neonatal and Preterm-SGA Working Groups. Her research focuses on the epidemiology of major neonatal diseases, and the design, evaluation, and implementation of interventions targeting these conditions in low-resource settings. Her projects are currently with the Projahnmo group in rural Sylhet, Bangladesh, and previously, with the Surmang Foundation, in a Tibetan region of Qinghai province, China.


Leslie Lehmann, MD

Director, Clinical Pediatric Stem Cell Transplantation Center, Dana-Farber Cancer Institute;; Associate Professor of Pediatrics, Harvard Medical School

Dr. Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children's Hospital Boston in 1996 and subsequently joined the faculty. In 1998, she became medical director of the Pediatric Transplant Unit at Children's Hospital and, in 2007, was appointed clinical director of the Pediatric Stem Cell Transplant Program.


Duncan Maru, MD, PhD

Research Faculty, Division of Global Health Equity, Brigham and Women’s Hospital; Attending Physician, Complex Care Service, Boston Children’s Hospital; Co-Founder & Chief Programs Officer, Possible Health; Instructor in Medicine, Harvard Medical School

Duncan Maru, MD, PhD, is Co-Founder, Chief Programs Officer, and a non-voting Board Member of Possible. He leads Possible’s healthcare delivery programs, develops and tests innovations for improving rural healthcare, and relentlessly builds healthcare partnerships. Duncan is a faculty member at Harvard Medical School through the Brigham and Women’s Division of Global Health Equity. He also practices part-time on the Complex Care Service at Boston Children’s Hospital. Duncan graduated from Harvard College, received his MD/PhD from Yale University, and completed the Harvard Combined Internal Medicine-Pediatrics Program and the Brigham and Women’s Global Health Equity Residency Program. Duncan’s work as a doctor and epidemiologist has generated over 35 peer-reviewed articles. Duncan's primary support is through the NIH Director's Common Fund Early Independence Award, a 5-year, $1.3 million grant for healthcare delivery research in rural Nepal. His research has additionally been supported by grants from the Charles Hood Foundation, Canada Global Challenges, and the Thrasher Early Career Award.


Kenneth McIntosh, MD

Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School;

I finished residency in 1965, spent 4 years doing research on respiratory viruses at the National Institutes of Health and then accepted a position as Chief of Pediatric Infectious Diseases at the University of Colorado Medical School in Denver, where I spent 10 years. In 1979 I was asked to be first Clinical Chief, and then Chief of the Division of Infectious Diseases at Boston Children’s Hospital. I stepped down from this position in 2000 and am now “semi-retired”. My research interests have been general pediatric infectious diseases, development of viral diagnostics, respiratory viruses (coronaviruses, respiratory syncytial virus, others), and, since 1985, pediatric HIV (its prevention, management, treatment, and complications). I became interested in global health in the early 1980’s, first in the application of simple viral diagnostics in global pediatrics, and later in the spread of the HIV epidemic in Africa and Asia.


Carlos Rodriguez-Galindo, MD

Director, Global Health Initiative, Dana-Farber Cancer Institute/Boston Children’s Hospital Cancer and Blood Disorders Center; Medical Director, Pediatric Oncology Clinical Trials, Dana-Farber Cancer Institute; Director, Solid Tumor Program, Pediatric Oncology, Dana-Farber Cancer Institute; Associate Professor of Pediatrics, Harvard Medical School;




Peter Rohloff, MD, PhD

Associate Physician, Department of Global Health Equity, Brigham and Women’s Hospital; Associate Physician, Department of General Internal Medicine, Brigham and Women’s Hospital; Associate Physician, Hospitalist Division, Dana Farber Cancer Institute; Instructor in Medicine, Harvard Medical School; Medical Director, Maya Health Alliance (Wuqu’ Kawoq); Contributing Author, Global Health Hub

I am a board-certified internist (BWH, 2012), pediatrician (BCRP, 2012) and parasitologist (PhD, University of Illinois, 2003). In addition to a strong background in tropical medicine and parasitic illnesses, I have been working as the Medical Director of a nongovernmental organization, the Maya Health Alliance, in Guatemala since 2007. When not in Central America, I work in the departments of General Internal Medicine and Global Health Equity at Brigham and Women’s Hospital. I also occasionally precept residents in an outpatient med-peds setting. My major research interests include the management of noncommunicable illnesses in resource poor settings, indigenous peoples and health disparities, and child stunting. I have a strong background in mixed methodologies in global health, especially those incorporating community participatory research and ethnography. I am the recent recipient of the HMS Dean’s Community Service Award (2010), Guatemala’s Order of the Monja Blanca, Second Class (2013), and the Velji Award for Faculty Teaching Excellence in Global Health from the Consortium of Universities for Global Health (2014).


Dennis Rosen, MD

Associate Medical Director, Center for Pediatric Sleep Disorders, Boston Children's Hospital; Assistant Professor of Pediatrics, Harvard Medical School;

I am a pediatric pulmonologist and sleep specialist at Boston Children’s Hospital, and have been here since 2001. I studied medicine at the Hebrew University of Jerusalem, graduating in 1996, and completed my pediatric residency in Israel in 2001 before coming to Boston for advanced training. Apart from my work in Israel, I have participated in three medical mission trips since 2010 to Haiti (Partners in Health and HUEH x1; Bernard Mevs hospital x2); and two to Guatemala (Iaomai and HELPS international). I have an interest in improving the communication between physicians and patients, the topic of my forthcoming book Vital Conversations: Improving Communication Between Doctors And Patients, to be published by Columbia University Press in September 2014. Within this area, I am especially interested in the effects of culture on this communication, as a consequence of differences in disease conceptualization, metaphor, illness behavior, sick roles as defined by society, and the existence of parallel belief systems among patients that physicians may be unaware of.


Sadath Sayeed, MD, JD

Director, Program in Newborn Health and Social Change, Harvard Medical School; Program Director for the Responsible Conduct of Research, Harvard Medical School; Assistant Professor of Global Health and Social Medicine, Harvard Medical School; Attending, Division of Newborn Medicine, Boston Children’s Hospital; Chief Medical Officer, Seed Global Health

Sadath A. Sayeed is assistant professor of global health and social medicine at Harvard Medical School where he serves as director of the Program in Newborn Health and Social Change. He is a staff neonatologist and assistant professor of pediatrics at Boston Children’s Hospital. He is also program director for the Responsible Conduct of Research at Harvard Medical School. Dr. Sayeed’s research focuses on the social and ethical determinants of early childhood survival in resource rich and poor settings. He is the author of several peer-reviewed papers and book chapters on the same. Dr. Sayeed is co-founder of The International Pediatric Outreach Project – now Global Strategies - a service and delivery-oriented non-profit organization that partners with health care providers in Africa and India. He is chief medical officer of Seed Global Health, partner to The Global Health Service Partnership with the United States Peace Corps. The Global Health Service Partnership sends doctors and nurses to sub-Saharan Africa as clinician educator volunteers for year assignments within local teaching institutions. Dr. Sayeed trained in pediatrics and neonatology at the University of California, San Francisco, and received his law degree from the University of Michigan.


Janet Scott Lloyd, MD

Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School;




Diane Stafford, MD

Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School;




Venee Tubman, MD

Senior Physician in Medicine, Division of Infectious Diseases, Boston Children’s Hospital; Professor of Pediatrics, Harvard Medical School;

 


Jill Veselik, MD

Attending Physician, St. Luke's Hospital (New Bedford, MA);

Jill received her B.A. from the University of Notre Dame, her medical degree from Loyola University Stritch School of Medicine and completed her pediatric residency at Loyola University Medical Center in Chicago, IL. She is board certified in pediatrics and is a recipient of Loyola’s Magis Spirit Award and Mullins Scholarship. Dr. Veselik has volunteered at the American Diabetes Association Teen Camp, the Chapin Street Clinic in South Bend, and volunteered in various international medical missions in Guatemala and Haiti. She developed a neonatal project in Rwanda as a Fellow in the Global Pediatric Fellowship at Boston Children’s Hospital. In her spare time, she enjoys long-distance running, competing in triathlons, and reading.

Julia von Oettingen, MD, Dr. Med

Fellow in Pediatric Endocrinology, Boston Children’s Hospital; Medical Director, Kay Mackenson Center (St. Marc, Haiti); Clinical Fellow in Pediatrics, Harvard Medical School; Committee Member, Massachusetts Medical Society Global Health Committee; Co-Director, Massachusetts Medical Society Global Health Student Conference; Council Member, Pediatric Endocrine Society International Relations Council;

Dr. von Oettingen is a fellow in pediatric endocrinology at Boston Children’s Hospital, and a master student in the Harvard Catalysts’ Master Program in Clinical and Translational Investigation. She completed her medical school training in her home country, Germany, and spent elective time in Brazil, Bulgaria, Burkina Faso, Peru and Canada. Her doctorate research was at McGill University in Montreal, Canada, in a tropical medicine and infectious diseases laboratory, and she graduated summa cum laude. She was a pediatric resident in Germany for a year before completing her pediatric training at Boston’s Massachusetts General Hospital for Children. Dr. von Oettingen’s global health work has focused on non-communicable diseases and health care infrastructure in Liberia and Haiti. She was involved with the development of a new model for pediatric primary care in Liberia, and led efforts to establish juvenile diabetes care in the country with a network of collaborators including pediatric endocrinologists, global health experts, local medical providers, diabetes patient activists and with major support from the International Diabetes Federation (IDF)’s Life for a Child program (www.idf.org/lifeforachild). In January 2013, Dr. von Oettingen took on the position of medical director of Kay Mackenson Center, a newly inaugurated pediatric chronic diseases clinic in Haiti. She provides and supervises clinical care, staff education, and is developing the center’s research program. Planned clinical research projects include the study of pediatric diabetes phenotypes, and the investigation of lead levels, iodine insufficiency and vitamin D status in Haitian children. Dr. von Oettingen speaks German, English, French, Spanish, Portuguese, and is conversational in Persian and Creole, allowing her to communicate with many of her patients in their native tongue. 


The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close